KCAS Bio is excited to expand our global reach by attending key conferences across Europe in 2025. These events bring together top experts in biotechnology, pharmaceuticals, and clinical research, providing a unique opportunity to discuss cutting-edge advancements, regulatory insights, and innovative solutions in bioanalytical and biomarker services. As we continue to support our clients in advancing drug development, we invite you to meet our experts at the following industry-leading events.
20th Congress of ECCO – European Crohn’s and Colitis Organisation
February 19–22, 2025 | Berlin, Germany
The ECCO Congress is the premier event for professionals dedicated to improving the care of patients with inflammatory bowel diseases. This event gathers researchers, clinicians, and industry leaders to explore the latest advancements in Crohn’s disease and ulcerative colitis. KCAS Bio will be on-site to discuss how our bioanalytical expertise supports the development of innovative treatments for these challenging conditions.
European Immunogenicity Platform (EIP)
February 24–26, 2025 | Lisbon, Portugal
The EIP symposium serves as a critical forum for discussing immunogenicity assessment, biologics, and novel therapeutic modalities. This year’s event will feature in-depth scientific discussions on assay development, immune response monitoring, and regulatory expectations. Our team at KCAS Bio will be available to share insights on our state-of-the-art bioanalytical solutions in immunogenicity testing.
World ADC – London 2025
March 3–6, 2025 | London, United Kingdom
World ADC London is a must-attend event for those working on antibody-drug conjugates (ADCs). With sessions covering novel linker-payload strategies, clinical progress, and manufacturing challenges, this conference highlights the latest advancements in ADC research. KCAS Bio is at the forefront of ADC bioanalysis, and we look forward to discussing how our hybrid LC-MS/MS and ligand-binding assay capabilities can support your development pipeline.
Alzheimer’s and Parkinson’s Diseases (AD/PD)
April 1–5, 2025 | Vienna, Austria
The AD/PD conference focuses on the latest breakthroughs in neurodegenerative disease research. From biomarkers to therapeutic interventions, this event gathers global experts to accelerate innovation in Alzheimer’s and Parkinson’s treatment. KCAS Bio is dedicated to supporting neurological drug development through specialized bioanalytical services, and we’re eager to collaborate on advancing precision medicine in this space.
German Biotech Days
April 9–10, 2025 | Heidelberg, Germany
As one of Germany’s leading biotechnology conferences, the German Biotech Days offer a platform for industry leaders, researchers, and investors to engage in discussions on the latest biotech innovations. KCAS Bio will be present to discuss our integrated bioanalytical and biomarker solutions that help accelerate drug discovery and development.
Swiss Biotech Day
May 5–6, 2025 | Basel, Switzerland
Swiss Biotech Day is a premier networking event for the European biotech sector. With a focus on investment, partnering, and innovation, this conference is a key event for professionals looking to advance biotechnology solutions. KCAS Bio’s experts will be on hand to explore how our advanced bioanalytical techniques can support biopharmaceutical advancements.
Healthtech Accelerations Summit 2025
June 26, 2025 | Paris, France
This summit brings together healthcare innovators, investors, and industry leaders to explore breakthroughs in medical technology and digital health. As bioanalytical science continues to intersect with cutting-edge healthcare solutions, KCAS Bio is excited to discuss how our expertise can drive innovation in this rapidly evolving landscape.
Dutch Biotech Event
June 27, 2025 | Maarssen, Netherlands
The Dutch Biotech Event is a vibrant gathering of biotech professionals focused on scientific advancements and industry growth. With a strong emphasis on collaboration and knowledge exchange, this event is an excellent opportunity to discuss the future of biotech innovation. KCAS Bio is looking forward to engaging with the Dutch biotech community and supporting the next wave of breakthroughs.
Let’s Connect in Europe!
KCAS Bio is committed to being at the forefront of bioanalytical advancements and regulatory compliance. As we participate in these prestigious European conferences, we invite you to schedule a meeting with our team to discuss how we can support your bioanalytical needs. Reach out to us today to set up a conversation at one of these events and discover how KCAS Bio can be your trusted partner in advancing drug development.